Location History:
- Wallingford, CT (US) (1996)
- Wethersfield, CT (US) (1998 - 2001)
- Pawtucket, RI (US) (2007)
- Annandale, VA (US) (2012)
Company Filing History:
Years Active: 1996-2012
Title: The Innovative Contributions of Stephen W. Mamber
Introduction
Stephen W. Mamber is a notable inventor based in Annandale, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of novel compounds. With a total of 6 patents to his name, Mamber's work has had a substantial impact on medical science.
Latest Patents
Among his latest patents, Mamber has developed cytotoxic xanthone compounds. These compounds are isolated from the plant Hochr. (Clusiaceae), a Madagascar plant, and are recognized as potent cytotoxic agents. Additionally, he has created the tyrissamycin antibiotic, which is a novel tyrosyl diester antibiotic obtained from the fermentation of a recombinant strain designated WD 15684 (ATCC-202143). This new antibiotic exhibits antibacterial activity, particularly against gram-positive bacteria.
Career Highlights
Mamber is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that address critical health challenges.
Collaborations
Some of his notable coworkers include Jingfang Qian Cutrone and Lyndon M. Foster. Their collaborative efforts have contributed to the success of various projects within the company.
Conclusion
Stephen W. Mamber's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of new medical treatments and compounds.